Analysis | Metabolite Name | Measured Value | Units | Diagnosis | Dysplasia |
---|---|---|---|---|---|
6530 Q-TOF/C18 NEGATIVE ION MODE | CITRULLINE (M-H)- | 2945 | Peak area | SCA | N/A |
6530 Q-TOF/C18 NEGATIVE ION MODE | CITRULLINE (M-H)- | 5025 | Peak area | MCN | LGD |
6530 Q-TOF/C18 NEGATIVE ION MODE | CITRULLINE (M-H)- | 11693 | Peak area | SCA | N/A |
6530 Q-TOF/C18 NEGATIVE ION MODE | CITRULLINE (M-H)- | 17303 | Peak area | IPMN | LGD |
6530 Q-TOF/C18 NEGATIVE ION MODE | CITRULLINE (M-H)- | Peak area | IPMN | LGD | |
6530 Q-TOF/C18 NEGATIVE ION MODE | CITRULLINE (M-H)- | Peak area | MCN | LGD | |
6530 Q-TOF/C18 NEGATIVE ION MODE | CITRULLINE (M-H)- | Peak area | SCA | N/A | |
6530 Q-TOF/C18 POSITIVE ION MODE | CITRULLINE (M+H)+ | 1499 | Peak area | IPMN | LGD |
6530 Q-TOF/C18 POSITIVE ION MODE | CITRULLINE (M+H)+ | 1751 | Peak area | SCA | N/A |
6530 Q-TOF/C18 POSITIVE ION MODE | CITRULLINE (M+H)+ | 4878 | Peak area | SCA | N/A |
6530 Q-TOF/C18 POSITIVE ION MODE | CITRULLINE (M+H)+ | 4910 | Peak area | SCA | N/A |
6530 Q-TOF/C18 POSITIVE ION MODE | CITRULLINE (M+H)+ | 5411 | Peak area | IPMN | LGD |
6530 Q-TOF/C18 POSITIVE ION MODE | CITRULLINE (M+H)+ | 7971 | Peak area | IPMN | LGD |
6530 Q-TOF/C18 POSITIVE ION MODE | CITRULLINE (M+H)+ | 18045 | Peak area | MCN | LGD |
6530 Q-TOF/C18 POSITIVE ION MODE | CITRULLINE (M+H)+ | Peak area | IPMN | LGD | |
6530 Q-TOF/C18 POSITIVE ION MODE | CITRULLINE (M+H)+ | Peak area | MCN | LGD | |
6530 Q-TOF/C18 POSITIVE ION MODE | CITRULLINE (M+Na)+ | 6738 | Peak area | SCA | N/A |
6530 Q-TOF/C18 POSITIVE ION MODE | CITRULLINE (M+Na)+ | 8783 | Peak area | IPMN | LGD |
6530 Q-TOF/C18 POSITIVE ION MODE | CITRULLINE (M+Na)+ | Peak area | IPMN | LGD | |
6530 Q-TOF/C18 POSITIVE ION MODE | CITRULLINE (M+Na)+ | Peak area | MCN | LGD | |
6530 Q-TOF/C18 POSITIVE ION MODE | CITRULLINE (M+Na)+ | Peak area | SCA | N/A |